Skip to main content

Fall Sale

20% off everything — GHK-Cu and Recon Water free over $250

Product group

Multi-Peptide Blends

A blend supplies two or more peptides lyophilized together in a single vial. Each blend in the catalog has its own Certificate of Analysis, and the compositions on this page are copied from those reports.

Sources last checked September 24, 2026. For laboratory research use only.

Products in this group

How these products are grouped

These four products are grouped by what the vial contains rather than by any shared property of the peptides. The label states the amount of each component and the total, and each product card above repeats the labeled amounts printed on that blend's report [1, 2, 3, 4].

How a blend is tested

A blend report differs from a single-compound report. Kovera Labs reports the blend as a whole, with an average purity by RP-HPLC, an average net content and an LC-MS identification of the blend, and then lists each component with its labeled and measured amount [1, 2, 3, 4].

The reports give no separate purity figure for each component, so none is stated on this site [1, 2, 3, 4].

Regulatory status

None of BPC-157, TB-500, GHK-Cu, KPV, CJC-1295 or ipamorelin is listed as an approved drug in the FDA's Drugs@FDA database (searched 24 September 2026) [5].

Every blend is supplied for laboratory research use only. None is for human or veterinary use.

Four of the components are also supplied as single compounds, each with its own batch report. TB-500 (TB-4) and ipamorelin are supplied only within blends.

  • BPC-157: Supplied on its own; a component of BPC-157 + TB-500, GLOW and KLOW.
  • GHK-Cu: Supplied on its own; a component of GLOW and KLOW.
  • KPV: Supplied on its own; a component of KLOW.
  • CJC-1295 no DAC: Supplied on its own; a component of CJC-1295 + Ipamorelin.

Identity data and batch reports

Each product page lists the compound's registry identity data with its source, and every published Certificate of Analysis for the batch supplied. Products without a published report say so.

References

  1. Kovera Labs Certificate of Analysis KVR-2026-47D7CA: BPC-157 + TB-500, certified 2026-08-24. Batch report. 2026. Source
  2. Kovera Labs Certificate of Analysis KVR-2026-6AA733: CJC-1295 + Ipamorelin, certified 2026-08-24. Batch report. 2026. Source
  3. Kovera Labs Certificate of Analysis KVR-2026-153C34: GLOW, certified 2026-08-24. Batch report. 2026. Source
  4. Kovera Labs Certificate of Analysis KVR-2026-E355F5: KLOW, certified 2026-08-24. Batch report. 2026. Source
  5. U.S. Food and Drug Administration Drugs@FDA: FDA-Approved Drugs (searched by active ingredient, 24 September 2026). accessdata.fda.gov. 2026. Source

All products are supplied for laboratory research use only. Not for human or veterinary use. This page describes how compounds are classified and makes no claim about any use of them.

vault